ALPINE, UT, May 25 /CNW/ - Clifton Mining Company (Clifton) (OTC:CFTN) announces
that American Biotech Labs (ABL), a private company in which Clifton holds a
25% interest, has recently signed an MOU with General Resonance(TM), LLC, to
form a Joint Venture.
General Resonance, a cutting-edge science and technology
company located in Maryland, scrutinized the science and technologies of ABL,
along with Professor Rustum Roy, who concurrently holds appointments with
The Pennsylvania State University, Arizona State
University and The University of Arizona. Professor
Roy helped found the number one ranked materials
science laboratory in the world, the Materials Research
Institute at The Pennsylvania State University. Professor
Roy is regarded as one of the top material scientists
in the world and sits on several countries' national academies of science.
In discussions regarding ABL products, General Resonance
(GR) was impressed with the scientific engineering
aspects, and the very high quality of ABL products;
ABL was equally impressed with GR's fundamental understanding of the engineering,
physics, and medical phenomena associated with ABL's products, as well as
GR's business and marketing background. As a result,
the companies have agreed to form a joint venture.
This ABL-GR Joint Venture will broaden and accelerate
the development and applications of ABL's engineered, silver nano-particles.
The combination of GR science and technology with ABL's existing products
and technologies creates a new scientific and commercial
synergy that promises to generate even greater
opportunities for the future. Clifton trades on the
U.S. OTC: (CFTN).
For further information: Dr.
Ken Friedman, President, (303) 642-0659; Keith Moeller, Vice President,
(801) 756-1414; or see our website at www.cliftonmining.com
|
